Inactive Instrument

Company Genetron Holdings Limited

Equities

GTH

US37186H2094

Biotechnology & Medical Research

Delayed Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
4.025 USD +0.12% Intraday chart for Genetron Holdings Limited +0.12% +9.38%

Business Summary

Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The Company operates its businesses primarily within the China market.

Number of employees: 993

Managers

Managers TitleAgeSince
Chief Executive Officer 48 14-12-31
Founder 57 14-12-31
Director of Finance/CFO 43 18-02-28
Chief Tech/Sci/R&D Officer 62 19-12-31
Chief Operating Officer 53 15-12-31
Chief Tech/Sci/R&D Officer 47 17-07-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 76 20-05-31
Director/Board Member 60 20-05-31
Director/Board Member 56 21-05-31
Founder 57 14-12-31
Chief Executive Officer 48 14-12-31
Director/Board Member 73 20-05-31
Director/Board Member 43 17-08-31
Director/Board Member 66 21-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 457,743,530 426,525,421 ( 93.18 %) 0 93.18 %

Company contact information

Genetron Holdings Ltd.

1-2F Building 11, Zone 1 8 Life Science Parkway

102206, Beijing

+

http://ir.genetronhealth.com
address Genetron Holdings Limited(GTH)
  1. Stock Market
  2. Equities
  3. GTH Stock
  4. Company Genetron Holdings Limited